Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Tofacitinib might be used to treat hair loss.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Itraconazole is potentially effective for treating invasive aspergillosis, but more research is needed.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

Certain medications, hypertension, and short eye length increase the risk of Intraoperative Floppy Iris Syndrome during cataract surgery.

Tamsulosin is a cost-effective treatment for BPH symptoms.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

The RISUG-PH™ implant effectively delivers finasteride to the prostate through the vas deferens.

Clascoterone may be a promising treatment for hair loss.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Combining different treatments may be needed to effectively manage chronic prostatitis.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

New treatments for male hair loss are being explored to improve effectiveness and reduce side effects.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.